Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1262-1270
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1262
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1262
Figure 1 Serum tumor markers in two groups of esophageal cancer patients.
A: The research group had markedly lower CA125 levels than the control group after treatment; B: The research group had markedly lower MIP-3α levels than the control group after treatment. aP < 0.05 vs control; bP < 0.01, vs before treatment. CA125: Carbohydrate antigen 125; MIP-3α: Macrophage inflammatory protein-3α.
- Citation: Zhang TW, Zhang P, Nie D, Che XY, Fu TT, Zhang Y. Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers. World J Gastrointest Oncol 2023; 15(7): 1262-1270
- URL: https://www.wjgnet.com/1948-5204/full/v15/i7/1262.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i7.1262